Otenabant

Otenabant
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T3530-2mg 2 mg -

7 - 10 business days*

41.00€
TGM-T3530-5mg 5 mg -

7 - 10 business days*

66.00€
TGM-T3530-1mL 1 ml -

7 - 10 business days*

74.00€
TGM-T3530-10mg 10 mg -

7 - 10 business days*

94.00€
TGM-T3530-25mg 25 mg -

7 - 10 business days*

179.00€
TGM-T3530-50mg 50 mg -

7 - 10 business days*

320.00€
TGM-T3530-100mg 100 mg -

7 - 10 business days*

478.00€
 
Description: Otenabant (CP-945598) has been investigated for the treatment of Obesity. Target:... more
Product information "Otenabant"
Description: Otenabant (CP-945598) has been investigated for the treatment of Obesity. Target: Cannabinoid Receptor. Smiles: CCNC1(CCN(CC1)c1ncnc2n(c(nc12)-c1ccccc1Cl)-c1ccc(Cl)cc1)C(N)=O. References: John R. Hadcock, et al. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1 receptor antagonist for the management of obesity. Biochemical and Biophysical Research Communications, 2010, 394,366-371.
Keywords: CP-945598
Supplier: TargetMol
Supplier-Nr: T3530

Properties

Application: Targets cannabinoid receptor 1 (CNR1)
MW: 510.42 D
Formula: C25H25Cl2N7O

Database Information

CAS : 686344-29-6| Matching products
KEGG ID : K04277 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Otenabant"
Write a review
or to review a product.
Viewed